| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
,
ARTHUR H. RUBENSTEIN and
KENNETH S. POLONSKY
Department of Medicine, University of Chicago, Pritzker School of Medicine Chicago, Illinois 60637
Address all correspondence and requests for reprints to: Kenneth S. Polonsky, M.D., Department of Medicine, Box 435, University of Chicago, 5841 South Maryland Avenue, Chicago, Illinois 60637.
The changes in peripheral serum insulin and plasma C-peptide levels and in the insulin secretory rate in response to iv glucose (0.5 g/kg BW) administration were studied in seven normal subjects. Insulin secretory rates were calculated according to a two-compartment model of distribution for Cpeptide, using individual C-peptide kinetics calculated from iv bolus injections of biosynthetic human C-peptide.
The mean plasma glucose level increased from a fasting level of 5.1 ± 0.1 (±SE) to a peak of 24.0 ± 1.0 mmol/L at 3 min and reached basal levels 101 ± 6 min after glucose administration. The mean serum insulin value increased from 50 ± 12 to a peak of 405 ± 58 pmol/L at 3 min and then declined to fasting levels 139 ± 14 min after the stimulus. In contrast, the mean plasma C-peptide level increased from 390 ± 50 to a peak of 1460 ± 210 pmol/L at 3 min and only began declining 45 min after glucose administration, reaching fasting levels 191 ± 15 min after the stimulus. The mean insulin secretory rate increased from 69.8 ± 19.9 to a peak of 1412.7 ± 159.1 pmol/min at 3 min (15.3 ± 2.5-fold elevation over baseline) and reached basal levels 135 ± 12 min after the stimulus. The clearance of endogenous insulin during the basal period (2.505 ± 0.365 L/min) and that during the 4 h after the stimulus (2.319 ± 0.230 L/min) were similar.
In conclusion, after bolus iv glucose administration: 1) the insulin secretory rate is more closely represented by changes in peripheral serum insulin than in plasma C-peptide levels; and 2) no change in endogenous insulin clearance occurs.
* This work was supported in part by Grant DK-31842 from the NIH, the Diabetes Research and Training Center (DK-20595), and the Clinical Research Center at the University of Chicago (RR-00055).
Supported by the Deutsche Forschungsgemeinschaft (Training Grant Ti 154/1-1) and the Deutsche Diabetes-Gesellschaft (Junior Science Award).
Recipient of a Research Career Development Award from the NIH (DK-01234).
Received January 27, 1988.
This article has been cited by other articles:
![]() |
G. Toffolo, M. Campioni, R. Basu, R. A. Rizza, and C. Cobelli A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E169 - E176. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Caumo and L. Luzi First-phase insulin secretion: does it exist in real life? Considerations on shape and function Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E371 - E385. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Palmer, G. A. Fleming, C. J. Greenbaum, K. C. Herold, L. D. Jansa, H. Kolb, J. M. Lachin, K. S. Polonsky, P. Pozzilli, J. S. Skyler, et al. C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve {beta}-Cell Function: Report of an ADA Workshop, 21-22 October 2001 Diabetes, January 1, 2004; 53(1): 250 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Watanabe, G. M. Steil, and R. N. Bergman Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E172 - E183. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |